{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:37:22Z","timestamp":1791837442000,"version":"4.3.4"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Chronic kidney disease (CKD), affecting 13% of the global population, is increasingly linked to gut microbiota dysbiosis, a condition driven by uremic toxins accumulation, metabolic alterations, and dietary factors. This mini review explores gut microbiota modulation as a therapeutic strategy to alleviate CKD symptoms, focusing on interventions that target gut microbiota composition and function. Prebiotics, such as resistant starch, have been shown to lower uremic toxins and reduce inflammation, while dietary adjustments, including low-protein and gluten-free diets, modulate microbial diversity and improve renal biomarkers. Fecal microbiota transplantation (FMT), which stabilizes creatinine levels and shifts gut microbiota toward beneficial taxa, represents another promising approach. However, limitations persist: synbiotics, which often induce gut microbiota shifts, frequently lack clinical impact; probiotics, which enhance glucose control and oxidative stress mitigation, exhibit variable efficacy; and interventions such as propolis or cranberry extract, which have been tested, prove ineffective. The causal relationship between gut microbiota dysbiosis and CKD progression, which remains unclear, is further complicated by methodological heterogeneity across studies. Emerging strategies, including phage therapy and artificial intelligence-driven multi-omics integration, which hold significant promise, require further validation. Future research must prioritize longitudinal studies, maternal gut microbiota optimization, and personalized approaches, which are essential for advancing CKD management. While gut microbiota modulations hold therapeutic potential, translating these findings into clinical practice demands rigorous trials to address inconsistencies and establish mechanistic links, ultimately shifting CKD management from reactive treatment to precision-based prevention.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1660226","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T05:24:01Z","timestamp":1757481841000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Gut microbiota therapy for chronic kidney disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Chunguang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12882-020-01805-w","article-title":"The gut microbiota profile of adults with kidney disease and kidney stones: a systematic review of the literature","volume":"21","author":"Stanford","year":"2020","journal-title":"BMC Nephrol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.620102","article-title":"Focus on the gut-kidney axis in health and disease","volume":"7","author":"Stavropoulou","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqac074","article-title":"Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis","volume":"116","author":"Li","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2020.1864404","article-title":"Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review","volume":"43","author":"Zhao","year":"2021","journal-title":"Ren Fail"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2174\/1871530323666221103120410","article-title":"Trimethylamine N-oxide as a potential risk factor for non-communicable diseases: A systematic review","volume":"23","author":"Hoseini-Tavassol","year":"2023","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2215542","article-title":"Gut microbiota-derived trimethylamine N-oxide is associated with the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and dose-response meta-analysis","volume":"55","author":"Li","year":"2023","journal-title":"Ann Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1018093","article-title":"A systematic review and meta-analysis of gut microbiota in diabetic kidney disease: Comparisons with diabetes mellitus, non-diabetic kidney disease, and healthy individuals","volume":"13","author":"Han","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1053900","article-title":"Specific alterations of gut microbiota in diabetic microvascular complications: A systematic review and meta-analysis","volume":"13","author":"Hong","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfac154","article-title":"Decreasing microbiota-derived uremic toxins to improve CKD outcomes","volume":"15","author":"Beker","year":"2022","journal-title":"Clin Kidney J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154079","article-title":"Efficacy and safety of Zicuiyin decoction on diabetic kidney disease: A multicenter, randomized controlled trial","volume":"100","author":"Liu","year":"2022","journal-title":"Phytomedicine"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/13880209.2024.2345080","article-title":"Yi-Shen-Hua-Shi regulates intestinal microbiota dysbiosis and protects against proteinuria in patients with chronic kidney disease: a randomized controlled study","volume":"62","author":"Dong","year":"2024","journal-title":"Pharm Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1480832","article-title":"Global research progress and trends in traditional Chinese medicine for chronic kidney disease since the 21st century: a bibliometric analysis","volume":"11","author":"Wang","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41392-024-01913-1","article-title":"Targeting Lactobacillus johnsonii to reverse chronic kidney disease","volume":"9","author":"Miao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1124704","article-title":"Gut microbiota and its metabolites - molecular mechanisms and management strategies in diabetic kidney disease","volume":"14","author":"Mao","year":"2023","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00345-023-04712-5","article-title":"Differential oral and gut microbial structure related to systemic metabolism in kidney stone patients","volume":"42","author":"Xu","year":"2024","journal-title":"World J Urol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.908219","article-title":"The specific alteration of gut microbiota in diabetic kidney diseases-A systematic review and meta-analysis","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.909491","article-title":"Specific alterations of gut microbiota in patients with membranous nephropathy: A systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Physiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/advances\/nmz028","article-title":"Gastrointestinal microbiota in patients with chronic kidney disease: A systematic review","volume":"10","author":"Chung","year":"2019","journal-title":"Adv Nutr"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2022020189","article-title":"Expansion of escherichia-shigella in gut is associated with the onset and response to immunosuppressive therapy of igA nephropathy","volume":"33","author":"Zhao","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"8805","DOI":"10.3390\/ijms23158805","article-title":"The effects of probiotics, prebiotics and synbiotics in non-alcoholic fat liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A systematic review","volume":"23","author":"Carpi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29657","article-title":"A multidisciplinary approach and current perspective of nonalcoholic fatty liver disease: A systematic review","volume":"14","author":"Zaman","year":"2022","journal-title":"Cureus"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.66451","article-title":"Effects of low protein diet on modulating gut microbiota in patients with chronic kidney disease: A systematic review and meta-analysis of international studies","volume":"18","author":"Hsu","year":"2021","journal-title":"Int J Med Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2014.237","article-title":"Dietary fiber effects in chronic kidney disease: a systematic review and meta-analysis of controlled feeding trials","volume":"69","author":"Chiavaroli","year":"2015","journal-title":"Eur J Clin Nutr"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.51484","article-title":"Benefits of resistant starch type 2 for patients with end-stage renal disease under maintenance hemodialysis: a systematic review and meta-analysis","volume":"18","author":"Jia","year":"2021","journal-title":"Int J Med Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2023.2187212","article-title":"Anthocyanins-gut microbiota-health axis: A review","volume":"64","author":"Liang","year":"2024","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.3390\/jcm10194456","article-title":"Effects of probiotics, prebiotics, and synbiotics on uremic toxins, inflammation, and oxidative stress in hemodialysis patients: A systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Nguyen","year":"2021","journal-title":"J Clin Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12866-023-02891-0","article-title":"Gut microbiota in patients with kidney stones: a systematic review and meta-analysis","volume":"23","author":"Yuan","year":"2023","journal-title":"BMC Microbiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.20960\/nh.1642","article-title":"Modulation of intestinal microbiota, control of nitrogen products and inflammation by pre\/probiotics in chronic kidney disease: a systematic review","volume":"35","author":"Lopes","year":"2018","journal-title":"Nutr Hosp"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2018.08.008","article-title":"Prebiotic, probiotic, and synbiotic supplementation in chronic kidney disease: A systematic review and meta-analysis","volume":"29","author":"McFarlane","year":"2019","journal-title":"J Ren Nutr"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1434613","article-title":"Efficacy of probiotics\/synbiotics supplementation in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Liu","year":"2024","journal-title":"Front Nutr"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/IMNA-D-23-00017","article-title":"Bibliometric analysis of the relationship between gut microbiota and chronic kidney disease from 2001\u20132022","volume":"11","author":"Tao","year":"2024","journal-title":"Integr Med Nephrol Andrology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/IMNA-D-23-00024","article-title":"Gut microbiota-derived metabolites: A new perspective of traditional chinese medicine against diabetic kidney disease","volume":"11","author":"Zhao","year":"2024","journal-title":"Integr Med Nephrol Andrology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.115359","article-title":"Tryptophan metabolism as a target in gut microbiota, ageing and kidney disease","volume":"21","author":"Miao","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16219","article-title":"Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites","volume":"181","author":"Miao","year":"2024","journal-title":"Br J Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1450428","article-title":"Causal relationship between 412 gut microbiota, 1,400 blood metabolites, and diabetic nephropathy: a randomized Mendelian study","volume":"15","author":"Cao","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1391891","article-title":"Elucidating the causal relationship between gut microbiota, metabolites, and diabetic nephropathy in European patients: Revelations from genome-wide bidirectional mendelian randomization analysis","volume":"15","author":"Song","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2022.07.008","article-title":"The impact of synbiotic treatment on the levels of gut-derived uremic toxins, inflammation, and gut microbiome of chronic kidney disease patients-A randomized trial","volume":"33","author":"Mitrovic","year":"2023","journal-title":"J Ren Nutr"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2018.08.024","article-title":"Synbiotic meal decreases uremic toxins in hemodialysis individuals: A placebo-controlled trial","volume":"116","author":"Lopes","year":"2019","journal-title":"Food Res Int"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2017.1334602","article-title":"Effect of a short-course treatment with synbiotics on plasma p-cresol concentration in kidney transplant recipients","volume":"36","author":"Guida","year":"2017","journal-title":"J Am Coll Nutr"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/1028415X.2019.1646975","article-title":"Effect of synbiotic and probiotic supplementation on serum brain-derived neurotrophic factor level, depression and anxiety symptoms in hemodialysis patients: a randomized, double-blinded, clinical trial","volume":"24","author":"Haghighat","year":"2021","journal-title":"Nutr Neurosci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/toxins12030170","article-title":"Efficacy of divinylbenzenic resin in removing indoxyl sulfate and P-cresol sulfate in hemodialysis patients: results from an in vitro study and an in vivo pilot trial (xuanro4-nature 3.2)","volume":"12","author":"Rocchetti","year":"2020","journal-title":"Toxins (Basel)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.09.040","article-title":"Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects","volume":"91","author":"Soleimani","year":"2017","journal-title":"Kidney Int"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.384189","article-title":"The role of prebiotics and probiotics as an adjuvant therapy in children with idiopathic relapsing nephrotic syndrome: A prospective open-label clinical trial","volume":"33","author":"Mohammed","year":"2022","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqz337","article-title":"Inulin-type fructan intervention restricts the increase in gut microbiome-generated indole in patients with peritoneal dialysis: a randomized crossover study","volume":"111","author":"Li","year":"2020","journal-title":"Am J Clin Nutr"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2019.110713","article-title":"Effects of synbiotic supplementation on microbiota-derived protein-bound uremic toxins, systemic inflammation, and biochemical parameters in patients on hemodialysis: A double-blind, placebo-controlled, randomized clinical trial","volume":"73","author":"Mirzaeian","year":"2020","journal-title":"Nutrition"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-020-02207-2","article-title":"Effect of probiotics on the intestinal microbiota of hemodialysis patients: a randomized trial","volume":"59","author":"Liu","year":"2020","journal-title":"Eur J Nutr"},{"key":"B48","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3390\/nu14040805","article-title":"The effect of ss-glucan prebiotic on kidney function, uremic toxins and gut microbiome in stage 3 to 5 chronic kidney disease (CKD) predialysis participants: A randomized controlled trial","volume":"14","author":"Ebrahim","year":"2022","journal-title":"Nutrients"},{"key":"B49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/ndt\/gfaa335","article-title":"Effect of fructooligosaccharide on endothelial function in CKD patients: a randomized controlled trial","volume":"37","author":"Armani","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.3390\/nu16121852","article-title":"A symbiotic meal containing extruded sorghum and probiotic (Bifidobacterium longum) ameliorated intestinal health markers in individuals with chronic kidney disease: A secondary analysis of a subsample from a previous randomized and controlled clinical trial","volume":"16","author":"Lucio","year":"2024","journal-title":"Nutrients"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3390\/nu14081637","article-title":"Probiotics-supplemented low-protein diet for microbiota modulation in patients with advanced chronic kidney disease (ProLowCKD): results from a placebo-controlled randomized trial","volume":"14","author":"De Mauri","year":"2022","journal-title":"Nutrients"},{"key":"B52","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/cam4.3569","article-title":"Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma","volume":"10","author":"Dizman","year":"2021","journal-title":"Cancer Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2021.10.003","article-title":"Diet quality and protein-bound uraemic toxins: investigation of novel risk factors and the role of microbiome in chronic kidney disease","volume":"32","author":"McFarlane","year":"2022","journal-title":"J Ren Nutr"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.3390\/nu12092799","article-title":"Compositional and functional adaptations of intestinal microbiota and related metabolites in CKD patients receiving dietary protein restriction","volume":"12","author":"Wu","year":"2020","journal-title":"Nutrients"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.624821","article-title":"Immunological impact of a gluten-free dairy-free diet in children with kidney disease: A feasibility study","volume":"12","author":"Perez-Saez","year":"2021","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-020-02392-3","article-title":"Resistant starch supplementation attenuates inflammation in hemodialysis patients: a pilot study","volume":"52","author":"de Paiva","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1590\/2175-8239-JBN-2020-0003","article-title":"Resistant starch supplementation effects on plasma indole 3-acetic acid and aryl hydrocarbon receptor mRNA expression in hemodialysis patients: Randomized, double blind and controlled clinical trial","volume":"42","author":"Azevedo","year":"2020","journal-title":"J Bras Nefrol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/hdi.12753","article-title":"Amylose resistant starch (HAM-RS2) supplementation increases the proportion of Faecalibacterium bacteria in end-stage renal disease patients: Microbial analysis from a randomized placebo-controlled trial","volume":"23","author":"Laffin","year":"2019","journal-title":"Hemodial Int"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202100374","article-title":"The impact of enriched resistant starch type-2 cookies on the gut microbiome in hemodialysis patients: A randomized controlled trial","volume":"65","author":"Kemp","year":"2021","journal-title":"Mol Nutr Food Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/nu14010231","article-title":"Curcumin supplementation (Meriva(\u00ae)) modulates inflammation, lipid peroxidation and gut microbiota composition in chronic kidney disease","volume":"14","author":"Pivari","year":"2022","journal-title":"Nutrients"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-020-02760-z","article-title":"Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study","volume":"53","author":"Salarolli","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/nu16081109","article-title":"Changes in the progression of chronic kidney disease in patients undergoing fecal microbiota transplantation","volume":"16","author":"Arteaga-Muller","year":"2024","journal-title":"Nutrients"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1523870","article-title":"Fecal microbiota transplantation-current perspective on human health","volume":"12","author":"Cao","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B64","doi-asserted-by":"publisher","first-page":"22935","DOI":"10.1038\/s41598-024-74171-4","article-title":"Safety and efficacy assessment of fecal microbiota transplantation as an adjunctive treatment for IgA nephropathy: an exploratory clinical trial","volume":"14","author":"Zhi","year":"2024","journal-title":"Sci Rep"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155398","article-title":"Efficacy and safety of Qushi Huayu, a traditional Chinese medicine, in patients with nonalcoholic fatty liver disease in a randomized controlled trial","volume":"130","author":"Liu","year":"2024","journal-title":"Phytomedicine"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1107071","article-title":"The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial","volume":"13","author":"Hui","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153561","article-title":"The effects of Fushen Granule on the composition and function of the gut microbiota during Peritoneal Dialysis-Related Peritonitis","volume":"86","author":"Lin","year":"2021","journal-title":"Phytomedicine"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1068613","article-title":"Natural products from plants and microorganisms: Novel therapeutics for chronic kidney disease via gut microbiota regulation","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Pharmacol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1097\/IMNA-D-23-00012","article-title":"Perspective on the modern interpretation of the property theory of mild-natured and sweet-flavored traditional chinese medicine via gut microbiota modulation","volume":"10","author":"Li","year":"2023","journal-title":"Integr Med Nephrol Andrology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s00018-024-05532-5","article-title":"Gut microbiota regulates oxidative stress and inflammation: a double-edged sword in renal fibrosis","volume":"81","author":"Li","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1430356","article-title":"Exploration of the pathogenesis of nephrotic syndrome and traditional Chinese medicine intervention based on gut microbiota","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.2174\/1389450122666210412141304","article-title":"The gut microbiota and traditional chinese medicine: A new clinical frontier on cancer","volume":"22","author":"Chen","year":"2021","journal-title":"Curr Drug Targets"},{"key":"B73","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3390\/toxins16100416","article-title":"Effects of propolis supplementation on gut microbiota and uremic toxin profiles of patients undergoing hemodialysis","volume":"16","author":"Fonseca","year":"2024","journal-title":"Toxins (Basel)"},{"key":"B74","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.clnesp.2023.11.015","article-title":"Can curcumin supplementation break the vicious cycle of inflammation, oxidative stress, and uremia in patients undergoing peritoneal dialysis","volume":"59","author":"Reis","year":"2024","journal-title":"Clin Nutr ESPEN"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05240515","article-title":"Synbiotics easing renal failure by improving gut microbiology (SYNERGY): A randomized trial","volume":"11","author":"Rossi","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.3390\/nu13124481","article-title":"Synbiotics easing renal failure by improving gut microbiology II (SYNERGY II): A feasibility randomized controlled trial","volume":"13","author":"McFarlane","year":"2021","journal-title":"Nutrients"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2024.108892","article-title":"Effects of probiotics and fibers on markers of nephropathy, inflammation, intestinal barrier dysfunction and endothelial dysfunction in individuals with type 1 diabetes and albuminuria. The ProFOS Study","volume":"38","author":"Stougaard","year":"2024","journal-title":"J Diabetes Complications"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-018-9411-1","article-title":"Effects of probiotic supplementation on trimethylamine-N-oxide plasma levels in hemodialysis patients: a pilot study","volume":"11","author":"Borges","year":"2019","journal-title":"Probiotics Antimicrob Proteins"},{"key":"B79","doi-asserted-by":"publisher","first-page":"31413","DOI":"10.1038\/s41598-024-83056-5","article-title":"Probiotic treatment induces changes in intestinal microbiota but does not alter SCFA levels in peritoneal dialysis patients-a randomized, placebo-controlled trial","volume":"14","author":"Zhou","year":"2024","journal-title":"Sci Rep"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2022.01.010","article-title":"Can resveratrol supplementation reduce uremic toxin plasma levels from the gut microbiota in nondialyzed patients with chronic kidney disease","volume":"32","author":"Alvarenga","year":"2022","journal-title":"J Ren Nutr"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03086-4","article-title":"Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial","volume":"30","author":"Ebrahimi","year":"2024","journal-title":"Nat Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3390\/nu13020646","article-title":"Effect of unripe banana flour on gut-derived uremic toxins in individuals undergoing peritoneal dialysis: A randomized, double-blind, placebo-controlled, crossover trial","volume":"13","author":"de Andrade","year":"2021","journal-title":"Nutrients"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2021.11.012","article-title":"Effect of cranberry supplementation on toxins produced by the gut microbiota in chronic kidney disease patients: A pilot randomized placebo-controlled trial","volume":"47","author":"Teixeira","year":"2022","journal-title":"Clin Nutr ESPEN"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1039\/d3fo01843a","article-title":"The arsenic-lowering effect of inulin-type prebiotics in end-stage renal disease: a randomized crossover trial","volume":"15","author":"Li","year":"2024","journal-title":"Food Funct"},{"key":"B85","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1053\/j.jrn.2017.06.010","article-title":"Probiotic supplementation in chronic kidney disease: A double-blind, randomized, placebo-controlled trial","volume":"28","author":"Borges","year":"2018","journal-title":"J Ren Nutr"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-021-02945-0","article-title":"Uremic toxins levels from the gut microbiota seem not to be altered by physical exercise in hemodialysis patients","volume":"54","author":"de Brito","year":"2022","journal-title":"Int Urol Nephrol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.34067\/kid.0003942020","article-title":"Randomized, placebo-controlled trial of rifaximin therapy for lowering gut-derived cardiovascular toxins and inflammation in CKD","volume":"1","author":"Kimber","year":"2020","journal-title":"Kidney360"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1177\/1535370218818175","article-title":"Fecal microbiota analysis of polycystic kidney disease patients according to renal function: A pilot study","volume":"244","author":"Yacoub","year":"2019","journal-title":"Exp Biol Med (Maywood)"},{"key":"B89","doi-asserted-by":"publisher","first-page":"12773","DOI":"10.1038\/s41598-021-91722-1","article-title":"Colonic dialysis can influence gut flora to protect renal function in patients with pre-dialysis chronic kidney disease","volume":"11","author":"Li","year":"2021","journal-title":"Sci Rep"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-021-03091-3","article-title":"Gut microbiome in hemodialysis patients treated with calcium acetate or treated with sucroferric oxyhydroxide: a pilot study","volume":"54","author":"Merino-Ribas","year":"2022","journal-title":"Int Urol Nephrol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1096093","article-title":"Time-restricted feeding\u2019s effect on overweight and obese patients with chronic kidney disease stages 3-4: A prospective non-randomized control pilot study","volume":"14","author":"Lao","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e0184789","DOI":"10.1371\/journal.pone.0184789","article-title":"Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial","volume":"12","author":"Yacoub","year":"2017","journal-title":"PloS One"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0801-z","article-title":"Effects of underfeeding and oral vancomycin on gut microbiome and nutrient absorption in humans","volume":"26","author":"Basolo","year":"2020","journal-title":"Nat Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8854969","article-title":"Gut microbiota profile in adult patients with idiopathic nephrotic syndrome","volume":"2021","author":"He","year":"2021","journal-title":"BioMed Res Int"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-018-1785-z","article-title":"An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD)","volume":"58","author":"Simeoni","year":"2019","journal-title":"Eur J Nutr"},{"key":"B96","doi-asserted-by":"publisher","first-page":"135\u2013","DOI":"10.1016\/j.nut.2017.07.001","article-title":"Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease","volume":"45","author":"Ottiger","year":"2018","journal-title":"Nutrition"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1125187","article-title":"The effects of prebiotics on gastrointestinal side effects of metformin in youth: A pilot randomized control trial in youth-onset type 2 diabetes","volume":"14","author":"Dixon","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy171","article-title":"Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial","volume":"34","author":"Ramos","year":"2019","journal-title":"Nephrol Dial Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1660226\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T05:24:02Z","timestamp":1757481842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1660226\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":98,"alternative-id":["10.3389\/fimmu.2025.1660226"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1660226","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"article-number":"1660226"}}